NLRP3 and inflammatory bowel disease: Inflammatory bowel disease, a complex inflammatory disorder, can be relieved by huc-MSCs-derived exosomes, which inhibit NLRP3 inflammasomes and cell pyroptosis through transferring miR-378a-5p [13].